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Abstract
Background: To assess the constants and formula for aphakia correction with iris-claw IOLs to achieve the best
refractive status in cases of late in-the-bag IOL complex dislocation.
Methods: A literature search was performed. The following data were obtained: Iris-claw IOL model, Iridal or
retroiridal enclavation, A-constant, ultrasound or optical biometry, formula employed and refractive outcomes.
Acceptable emmetropia was considered if the resulting spherical equivalent (SE) was within ±1.00 D.
Results: The majority of the studies used SRK/T formula (66.6%). The 88.9% of the reports obtained a SE within ±1.
00 D. Using A-115 for ultrasound biometry and A-115.7 for optical biometry and SRK/T formula, the emmetropia
(±1.00 D) of SE, was able to get near 100% of reported cases over the pupil implantation. However, the emmetropia
decreased to 80% when the enclavation is retropupilar using the same formula. The A-constant can vary from 116.7
to 117.5 for retropupilar enclavation.
Conclusions: Using A-115 for ultrasound biometry and A-115.7 for optical biometry and SRK/T formula, ±1.00 D of
SE, is able to get near 100% of cases. Nevertheless, ±1.00 D of SE decreased to 80% of the cases when the
enclavation is retropupilar.
Keywords: IOL-in-the bag dislocation, Iris-claw IOL, Late cataract surgery complication, Artisan aphakia, Verysise
Background
Decentration or luxation of a posterior chamber intraocu-
lar lens (IOL) is an uncommon problem following cataract
surgery. The phenomenon late in-the-bag IOL complex
dislocation after an uneventful cataract surgery can occur
many years postoperatively, due to previous progressive
zonular disintegration and capsular shrinkage [1–6].
Pseudoexfoliation syndrome is present in more than
50% of the reported cases [6]. Other risk factors such as
advanced age, high myopia, uveitis, trauma, previous
vitreoretinal surgery, diabetes mellitus and connective tis-
sue disorders may be also associated [6]. Complications
during cataract surgery and advanced status of the cata-
ract also increased the risk of late in-the-bag IOL disloca-
tion [7]. No significant differences have been found
following extracapsular cataract extraction when com-
pared with phacoemulsification [8]. However, a long
phacoemulsification time may be also a risk factor [9].
Although, the cumulative risk of IOL dislocation remains
low after cataract surgery, an increased occurrence of late
in-the-bag IOL dislocation can be expected in postopera-
tive years due to life expectancy [5]. On the other hand,
high myopia may be the main risk factor in other studies
[10]. Many myopic refractive procedures have been per-
formed by means of clear lens extraction. After a 10-years
follow-up a 0.6% of cases may require a surgical procedure
for a dislocated IOL [11]. Until now, it is not clear if this
percentage could increase in cases operated of myopia in
future years.
The mean time after cataract extraction and a sec-
ondary surgery for late in-the-bag IOL dislocation is
approximately 8.5 years [12–14]. When in-the-bag IOL
dislocation occurs, due to the risk of further decentration,
it is usually better to perform surgery while an anterior
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approach is still possible. Iris-claw lens insertion has been
shown their utility in acquired aphakia conditions in the
overwhelming majority of cases, with little evidence of
post-operative problems such as uveitis, glaucoma, or
hyphema [15–17]. The exchange of the dislocated IOL-
bag complex and implantation of an iris-claw IOL for
aphakia correction during the same time may be a safe
and predictable technique with minimal complications
[18]. Many reports with iris-claw IOL implantation for
correction of this syndrome have been reported. Never-
theless, there is no consensus about the A-constant and
the employed formula for determining IOL power. In the
majority of studies, the authors do not mention about A
constant and employed formula [19]. This fact constitutes
a challenge for achieving an emmetropia when the extrac-
tion and implantation of an iris-claw IOL would be at the
same time.
The aim of the study is to assess readers in the best A-
constant and formula employed in different studies report-
ing aphakia correction with iris-claw IOLs to achieve the
best refractive status following surgery in cases of late in-
the-bag IOL complex dislocation.
Methods
A literature search was performed using Pubmed and
Google Scholar until February 2017. The keywords used
were: late in-the-bag IOL dislocation, IOL luxation, cata-
ract and pseudoexfoliation syndrome, iris-claw IOL and
aphakia, Artisan aphakia, Verisyse aphakia. References
cited in the identified reports were also reviewed. Only the
reports that have reference to iris-claw IOL implantation
in cases of in-the-bag IOL dislocation in the same time
were considered. From the articles identified, the following
data were obtained if were referenced: Iris-claw IOL
model, Iridal (over the pupil) or retroiridal (retropupillary)
enclavation, A-constant, ultrasound or optical biometry,
formula employed and refractive outcomes. Reports that
do not refer the majority above mentioned data in the ma-
terial and methods were discarded. From the reports that
have reference to this situation only the cases operated in
the same time dislocated complex IOL bag extraction and
implantation of iris-claw in the same time were choosen
for the study. Acceptable emmetropia was considered if
the resulting spherical equivalent (SE) was within ±1.00 D.
The A-constant provided by the manufacturer of the iris-
claw IOLs (Opthec, 9700 AJ Groningen, The Netherlands)
were also consulted [20].
Results
Data provided by the manufacturer
Regarding refractive iris-claw IOLs in phakic conditions
keratometry and anterior chamber depth (ACD) were
taken into account for the power IOL calculation by
means of a calculator [20]. The van der Heijde formula
is usually employed in phakic conditions [21]. van der
Heijde formula is a theoretical formula of first generation.
The problem with this formula is the need to predict from
the preoperative data the position that the IOL will take
within the eye in a pseudophakic eye. Do not confuse
pseudophakic anterior chamber depth (ACD) with pre-
operative phakic ACD.
The A-constant provided by the manufacturer is 115.0
(ultrasound) and 115.7 (optical biometry) for Artisan®
aphakia IOL (model 205, Ophtec, Groeningen, The
Neederlands) for the SRK/T formula. There are available
powers from +2.00 to +30.00 D [22]. Verisyse® IOL for
aphakia model VRS54 from Abott (Abott Laboratories,
Santa Clara, US) is the same IOL that Artisan® aphakia
model 205 from Ophtec aproved by the FDA in United
States [23]. The A-constant is the same. Refractive
models for myopia correction may be employed in
special situations because there is not a power lower
than +2.00 D for Artisan® aphakia IOL [24].
Data of the revised manuscripts
Many reports treat the beneficial outcomes after an iris-
claw IOL implantation to resolve the aphakia. However,
there are few reports that have reference to the
employed biometry, constant and final spherical out-
comes after dislocated IOL-bag extraction and iris-claw
implantation. Many consulted studies did not report the
A-constant and formula employed and, therefore, they
were discarded. Table 1 summarizes the eight reviewed
reports with the number of cases relating the procedure
in the same time and refractive outcomes after the iris-
claw IOL enclavement in this situation. Many of them
report the iris-claw IOLs implant in other situations.
There are articles describing isolated case reports in
special situations as high myopia [24]. Most of reports
describe the implantation of an Artisan® aphakia 205
iris claw IOL or Verisyse® iris claw IOL.. From the se-
lected studies the majority (66.6%) used SRK/T formula.
Only one of them modified the formula for a specific
case associated to high myopia using the T2 formula
[24, 25]. The Haigis formula was used in two reports
[26, 27]. Holladay 2 and Hoffer Q were referenced only
in a report [26]. In cases over the pupil implantation,
the A-constant employed is 115 for presumably ultra-
sound biometry [16] and 115.7 for optical biometry
[18]. A-103.8 was used when an Artisan myopia®
model was used to correct the aphakic situation [24].
A-constant for retropupilary enclavation with SRK/T
formula varies from 116.7 to 117.5 [24, 26, 28, 29]. A0
constant used for Haigis formula differ in two reports
[26, 27]. The 88.9% of the reports obtained a SE within
±1.00 D [16, 18, 24–27, 29]. In the 44.4% the enclava-
tion was over the pupil and generally the SRK/T for-
mula was employed [16, 18, 24, 30]. In the 55.6% of
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reports the enclavation was retroiridal [23, 26–29, 31]
and the SRK/T formula was employed in the 80% of
the reports [23, 26, 28, 29]. With this formula almost
60% of cases could achieved the emmetropia within
±1.00 D. However, differences on the A-constant
employed are notable between all reports. A-116.9 for
optical biometry may be the mean for the SRK/T for-
mula in large reported series that employer retroiridal
enclavement [23, 32].
Discussion
Surgical correction of the aphakia results in a challen-
ging decision and approach. One solution may be the
reposition and suture of the IOL to the scleral wall
[33]. The advantage of repositioning and suturing the
IOL is that it may avoid a large incision and astigma-
tism induction. Nevertheless, in some cases this tech-
nique is not possible because either IOL is dislocated
into the vitreous cavity or vitreous appears into the
anterior chamber. An exchange of the IOL-bag com-
plex may be preferable in these situations. Angle
supported IOLs or iris-claw IOLs may resolve the
aphakia at the same time of surgery or in a second
time. However, anterior chamber angle supported
IOLs are not popular because they may produce cor-
neal decompensation in compromised corneas [34].
Another possibility is the scleral-fixated PC-IOLs, but
they may produce lens tilting and decentration among
others [34–36].
There are few reports about treatment of aphakia in
the late in-the-bag dislocation with an iris claw IOL.
Description about the formula and A-constant employed
are summarized in Table 1. Retroiridal enclavation is re-
ported more frequently in the last time. The theoretical
advantage of this location is to avoid the endothelial cell
loss [37]. However, the largest series reported show no
significant endothelial cells loss after over the pupil
enclavation [38, 39]. A study showed that there were no
differences in endothelial cells count between three tech-
niques for aphakia correction: anterior fixated iris claw,
posterior iris fixated IOL and scleral-fixated IOL [40].
The percentage of endothelial cells loss can vary in the
different studies between 5.5 and 11.7% according to
their follow-up [37, 41]. The majority conclude that the
major loss occurs during the first year, due to the surgi-
cal trauma during the implantation as it occurs with the
implantation of phakic iris claw IOLs [42]. According to
these results, anterior or posterior enclavation of the iris
claw depend of the decision, ability and preference of
the surgeon.
Most authors report the implantation of an iris claw
IOL to resolve the refractive status after aphakia, trauma,
vitrectomy or complicated cataract surgery. However, an
iris-claw IOL may be implanted at the same time of the
extraction of the dislocated IOL-bag complex. Because of
this, it is necessary to observe the reported refractive out-
comes with the use of iris-caw IOLs for aphakia.
We observe eight studies reporting cases with ex-
plantation of the dislocated IOL-bag complex and im-
plantation of an iris-claw at the same time [16, 18, 23,
24, 26–30]. Since many refractive procedures have been
performed by means of clear lens extraction and IOL
implantation in myopic population, it is probable in a
higher frequency of late in-the-bag IOL dislocation
cases in the future. The duration of surgery and pseu-
doexfoliation syndrome may increase the possibility of
this syndrome about 8.5 years later [9–11, 43, 44]. In
this sense, it is possible to perform the extraction of the
dislocated complex and implantation of an iris claw
IOL due the above mentioned advantages and get close
to emmetropia.
Emmetropia can be achieved within ±1.00 D of SE
near of 100% of cases using the SRK/T formula in cases
over the pupil enclavement using the A-constants of
the manufacturer [16, 18, 24, 30] and also near 80% of
cases with the same formula for posterior enclavement.
Nevertheless, for posterior enclavation there are no
clear consensus for A-constant employed in this study
[23, 26, 28, 29]. Although, with an A-constant of 116.9
the emmetropia can be achieved within ±1.00 D of SE
in other study about retroiridal enclavation of an iris-
claw IOL [32]. For the cases out of ±1.00 D of SE the
corneal curvature and axial length should be considered
and optimized constants for SRK/T, Haigis, Hoffer Q,
and Holladay 1 formulas as for primary IOL implant-
ation during cataract surgery or refractive lens ex-
change should be necessary to minimize the deviation
between postoperative refraction and the target refrac-
tion. The revised studies have employed mostly the
SRK/T. An alternative may be the Holladay 2 formula
used in a study with megalocornea [45] or modification
of SRK/T employed in another one in cases of high my-
opia [23]. The great SE deviation is observed in the re-
port that use all formula [26]. When the Haigis formula
is used emmetropia can be achieved; however, a great
standard deviation is observed [27].
Conclusions
The iris-claw IOL implantation may be a safe and pre-
dictable method to correct the aphakia at the same time
in cases of late in-the-bag IOL dislocation. Better stan-
dardized constants and the possibility of 4th formula
generation (Olsen, Barrett, Hill, etc.) should be consid-
ered to obtain the emmetropia. This would be especially
necessary in cases of retroiridal implantation. Currently,
there is no literature on the latest formulas and the use
of iris-claw IOLs.
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